PF127 hydrogel-assisted in-situ Staphylococcus aureus biofilm fabrication endowing pathological animal model for chronic osteomyelitis
- 1Department of Orthopaedics, The Second Affiliated Hospital of XuZhou Medical University
- 2Graduate School of Xuzhou Medical University, Xuzhou
- 3China University of Mining and Technology, Xuzhou
Abstract
Chronic osteomyelitis driven by biofilms remains difficult to treat and thus the exploration of its clinical therapy and pathological mechanism largely depend on effective animal models. However, standardized and efficient methods for establishing stable and reproducible animal models for chronic osteomyelitis are still lacking. This study developed a Hydrogel Assisted In-situ Biofilm Fabrication (HAIBF) method by coupling thermosensitive Pluronic F-127 (PF127) hydrogel with biofilm fragments, which stably mimic the pathological process of biofilm-infected chronic osteomyelitis. Forty-eight rats were randomly allocated into four groups: a planktonic bacteria injection group, a direct biofilm injection group, a PF127-loaded biofilm injection group, and a blank control group. Rats were euthanized, and tibial samples were harvested once a week for the following month after infection. Macroscopic examination, SEM, CLSM, micro-CT with three-dimensional reconstruction and quantitative analysis, and H&E staining were combined to evaluate biofilm localization, bone destruction, and tissue pathology. PF127 facilitated the stable localization of biofilm within bone tissue. Collectively, these results validated the successful establishment of a chronic osteomyelitis model characterized by persistent biofilm infection, pathological bone remodeling, and impaired bone repair. HAIBF integrates low-metabolism biofilm fragments with an injectable, thermoresponsive PF127 hydrogel to establish an implant-free bone infection model that undergoes in situ gelation and promotes the local retention of biofilm-derived material. Within a relatively short infection progression period, this model reliably reproduces persistent biofilm-associated infection and selected pathological features of chronic osteomyelitis, thereby providing a more stable and consistent experimental platform for mechanistic studies and therapeutic evaluation.
Related
- From Heart Murmur to Bone Involvement: Tricuspid Valve Endocarditis With First-Rib Osteomyelitis in a Patient With Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia
- First characterization of Staphylococcus felis in diabetic foot osteomyelitis: from intracellular persistence to phage treatment
- Feline-Derived Lactiplantibacillus plantarum-Aloe Vera Polysaccharide Hydrogel as a Topical Control Strategy for Staphylococcus pseudintermedius-Infected Wounds.
- Development and content validity of an AI-assisted simulation scenario for orthotic fabrication in occupational therapy education
- Impact of MRI-to-surgery interval on pathological upstaging after robot-assisted radical prostatectomy: a real-world cohort study.
BibTeX
@article{wang2026pf127,
title = {{PF127 hydrogel-assisted in-situ Staphylococcus aureus biofilm fabrication endowing pathological animal model for chronic osteomyelitis}},
author = {Jiawen Wang and Fuchao Chu and Qing Zhang and Xiangyu Qi and Liudong Zhang and Xu Zhang and Yazhong Zhang and Yongxiang Lv and Wenbo Li and Na Cai and Dekun Zhang and Ziqiang Zhu},
journal = {Frontiers in Microbiology},
year = {2026},
month = oct,
doi = {10.3389/fmicb.2026.1914727},
url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.1914727/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - PF127 hydrogel-assisted in-situ Staphylococcus aureus biofilm fabrication endowing pathological animal model for chronic osteomyelitis
AU - Jiawen Wang
AU - Fuchao Chu
AU - Qing Zhang
AU - Xiangyu Qi
AU - Liudong Zhang
AU - Xu Zhang
AU - Yazhong Zhang
AU - Yongxiang Lv
AU - Wenbo Li
AU - Na Cai
AU - Dekun Zhang
AU - Ziqiang Zhu
PY - 2026
DA - 2026/10/05
JO - Frontiers in Microbiology
DO - 10.3389/fmicb.2026.1914727
UR - https://www.frontiersin.org/articles/10.3389/fmicb.2026.1914727/full
AB - Chronic osteomyelitis driven by biofilms remains difficult to treat and thus the exploration of its clinical therapy and pathological mechanism largely depend on effective animal models. However, standardized and efficient methods for establishing stable and reproducible animal models for chronic osteomyelitis are still lacking. This study developed a Hydrogel Assisted In-situ Biofilm Fabrication (HAIBF) method by coupling thermosensitive Pluronic F-127 (PF127) hydrogel with biofilm fragments, which stably mimic the pathological process of biofilm-infected chronic osteomyelitis. Forty-eight rats were randomly allocated into four groups: a planktonic bacteria injection group, a direct biofilm injection group, a PF127-loaded biofilm injection group, and a blank control group. Rats were euthanized, and tibial samples were harvested once a week for the following month after infection. Macroscopic examination, SEM, CLSM, micro-CT with three-dimensional reconstruction and quantitative analysis, and H&E staining were combined to evaluate biofilm localization, bone destruction, and tissue pathology. PF127 facilitated the stable localization of biofilm within bone tissue. Collectively, these results validated the successful establishment of a chronic osteomyelitis model characterized by persistent biofilm infection, pathological bone remodeling, and impaired bone repair. HAIBF integrates low-metabolism biofilm fragments with an injectable, thermoresponsive PF127 hydrogel to establish an implant-free bone infection model that undergoes in situ gelation and promotes the local retention of biofilm-derived material. Within a relatively short infection progression period, this model reliably reproduces persistent biofilm-associated infection and selected pathological features of chronic osteomyelitis, thereby providing a more stable and consistent experimental platform for mechanistic studies and therapeutic evaluation.
SN - 1664-302X
ER -